PEDF: a potential molecular therapeutic target with multiple anti-cancer activities

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Sebolt-Leopold, 2006, Mechanisms of drug inhibition of signalling molecules, Nature, 441, 457, 10.1038/nature04874 Jimeno, 2006, Multitargeted therapy: can promiscuity be praised in an era of political correctness?, Crit. Rev. Oncol. Hematol., 59, 150, 10.1016/j.critrevonc.2006.01.005 Eastman, 2006, New targets and challenges in the molecular therapeutics of cancer, Br. J. Clin. Pharmacol., 62, 5, 10.1111/j.1365-2125.2006.02720.x Klein, 2005, Killing time for cancer cells, Nat. Rev. Cancer, 5, 573, 10.1038/nrc1651 Tombran-Tink, 1989, Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells, Invest. Ophthalmol. Vis. Sci., 30, 1700 Tombran-Tink, 1991, PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity, Exp. Eye Res., 53, 411, 10.1016/0014-4835(91)90248-D Dawson, 1999, Pigment epithelium-derived factor: a potent inhibitor of angiogenesis, Science, 285, 245, 10.1126/science.285.5425.245 Zhang, 2006, Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor, FASEB J., 20, 323, 10.1096/fj.05-4313fje Yamagishi, 2005, Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF, Cell Tissue Res., 320, 437, 10.1007/s00441-005-1094-8 Funatsu, 2006, Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema, Ophthalmology, 113, 294, 10.1016/j.ophtha.2005.10.030 Hase, 2005, Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice, Clin. Cancer Res., 11, 8737, 10.1158/1078-0432.CCR-05-1323 Filleur, 2005, Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer, Cancer Res., 65, 5144, 10.1158/0008-5472.CAN-04-3744 Doll, 2003, Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas, Nat. Med., 9, 774, 10.1038/nm870 Ramirez-Castillejo, 2006, Pigment epithelium-derived factor is a niche signal for neural stem cell renewal, Nat. Neurosci., 9, 331, 10.1038/nn1657 Tsao, 2006, Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells, Life Sci., 79, 545, 10.1016/j.lfs.2006.01.041 Takanohashi, A. et al. (2006) Pigment epithelium-derived factor induces the production of chemokines by rat microglia. Glia [Epub ahead of print] Ek, 2006, The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas, Expert Rev. Anticancer Ther., 6, 225, 10.1586/14737140.6.2.225 Steele, 1993, Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family, Proc. Natl. Acad. Sci. U. S. A., 90, 1526, 10.1073/pnas.90.4.1526 Tombran-Tink, 1996, Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin, Mol. Vis., 2, 4 Bilak, 1999, Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration, J. Neuropathol. Exp. Neurol., 58, 719, 10.1097/00005072-199907000-00006 Kuncl, 2002, Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis, J. Neurochem., 81, 178, 10.1046/j.1471-4159.2002.00813.x Sawant, 2004, Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature, Biochem. Biophys. Res. Commun., 325, 408, 10.1016/j.bbrc.2004.10.041 Uehara, 2004, Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma, Cancer Res., 64, 3533, 10.1158/0008-5472.CAN-03-3725 Quan, 2005, Localization of pigment epithelium-derived factor in growing mouse bone, Calcif. Tissue Int., 76, 146, 10.1007/s00223-004-0068-2 Alberdi, 1998, Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site, Biochemistry, 37, 10643, 10.1021/bi9802317 Bilak, 2002, Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons, J. Neurosci., 22, 9378, 10.1523/JNEUROSCI.22-21-09378.2002 Meyer, 2002, Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity, J. Biol. Chem., 277, 45400, 10.1074/jbc.M208339200 Alberdi, 1999, Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor, J. Biol. Chem., 274, 31605, 10.1074/jbc.274.44.31605 Aymerich, 2001, Evidence for pigment epithelium-derived factor receptors in the neural retina, Invest. Ophthalmol. Vis. Sci., 42, 3287 Volpert, 2002, Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor, Nat. Med., 8, 349, 10.1038/nm0402-349 Patricia Becerra, 2006, Focus on molecules: pigment epithelium-derived factor (PEDF), Exp. Eye Res., 82, 739, 10.1016/j.exer.2005.10.016 Yasui, 2003, Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF, Biochemistry, 42, 3160, 10.1021/bi0206558 Hosomichi, 2005, Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor, Biochem. Biophys. Res. Commun., 335, 756, 10.1016/j.bbrc.2005.07.140 Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108 Tombran-Tink, 2003, PEDF: a multifaceted neurotrophic factor, Nat. Rev. Neurosci., 4, 628, 10.1038/nrn1176 Halin, 2004, Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors, Cancer Res., 64, 5664, 10.1158/0008-5472.CAN-04-0835 Uehara, 2004, Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma, Cancer Res., 64, 3533, 10.1158/0008-5472.CAN-03-3725 Guan, 2003, Loss of pigment epithelium derived factor expression in glioma progression, J. Clin. Pathol., 56, 277, 10.1136/jcp.56.4.277 Sidle, 2005, Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence, Arch. Otolaryngol. Head Neck Surg., 131, 990, 10.1001/archotol.131.11.990 Bouck, 2002, PEDF: anti-angiogenic guardian of ocular function, Trends Mol. Med., 8, 330, 10.1016/S1471-4914(02)02362-6 Cai, 2006, Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of VEGFR-1, J. Biol. Chem., 281, 3604, 10.1074/jbc.M507401200 Ogata, 2001, Upregulation of pigment epithelium-derived factor after laser photocoagulation, Am. J. Ophthalmol., 132, 427, 10.1016/S0002-9394(01)01021-2 Holekamp, 2002, Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration, Am. J. Ophthalmol., 134, 220, 10.1016/S0002-9394(02)01549-0 Quan, G.M. et al. (2002-2003) Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors. Pathobiology 70, 361–367 Takenaka, 2005, Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells, Life Sci., 77, 3231, 10.1016/j.lfs.2005.05.048 Zhang, 2006, Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome, Int. J. Mol. Med., 17, 937 Abe, 2004, Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo, Am. J. Pathol., 164, 1225, 10.1016/S0002-9440(10)63210-5 Garcia, 2004, Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor, Cancer Res., 64, 5632, 10.1158/0008-5472.CAN-04-0230 Streck, 2005, Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth, J. Pediatr. Surg., 40, 236, 10.1016/j.jpedsurg.2004.09.049 Abramson, 2003, Wilms’ tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model, J. Pediatr. Surg., 38, 336, 10.1053/jpsu.2003.50104 Crawford, 2001, Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity, J. Cell Sci., 114, 4421, 10.1242/jcs.114.24.4421 Zhang, 2005, Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro, Oncol. Rep., 14, 1615 Quan, 2005, Localization of pigment epithelium-derived factor in growing mouse bone, Calcif. Tissue Int., 76, 146, 10.1007/s00223-004-0068-2 Li, 2006, A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres, Exp. Eye Res., 83, 824, 10.1016/j.exer.2006.04.014